LEVODOPA - PHARMACOLOGY, PHARMACOKINETICS, AND PHARMACODYNAMICS

被引：35
|
作者：
JUNCOS, JL [1 ]
机构：
[1] EMORY UNIV, SCH MED, MOVEMENT DISORDERS PROGRAM, ATLANTA, GA 30322 USA
来源：
NEUROLOGIC CLINICS | 1992年 / 10卷 / 02期
关键词：
D O I：
10.1016/S0733-8619(18)30223-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：487 / 509
页数：23
相关论文
共 50 条
  • [1] Pharmacokinetics and pharmacodynamics of levodopa
    Nutt, John G.
    MOVEMENT DISORDERS, 2008, 23 : S580 - S584
  • [2] PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA
    MONTGOMERY, EB
    NEUROLOGY, 1992, 42 (01) : 17 - 22
  • [3] The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa
    Reuter, I
    Harder, S
    Engelhardt, M
    Baas, H
    MOVEMENT DISORDERS, 2000, 15 (05) : 862 - 868
  • [4] PHARMACOLOGY, PHARMACODYNAMICS AND PHARMACOKINETICS OF SOTALOL
    ANTONACCIO, MJ
    GOMOLL, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (02): : A12 - A21
  • [5] Ximelagatran: Pharmacology, pharmacokinetics, and pharmacodynamics
    Dobesh, PP
    PHARMACOTHERAPY, 2004, 24 (10): : 169S - 178S
  • [6] Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics
    Kompoliti, K
    Adler, CH
    Raman, R
    Pincus, JH
    Leibowitz, MT
    Ferry, JJ
    Blasucci, L
    Caviness, JN
    Leurgans, S
    Chase, WM
    Yones, LC
    Tan, E
    Carvey, P
    Goetz, CG
    NEUROLOGY, 2002, 58 (09) : 1418 - 1422
  • [7] Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics
    Zappia, M
    Quattrone, A
    NEUROLOGY, 2002, 59 (12) : 2010 - 2010
  • [8] Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics
    Turnidge, J
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 12 : S23 - S34
  • [9] Effects of caffeine on levodopa pharmacokinetics and pharmacodynamics in Parkinson disease
    Deleu, D.
    Jacob, P.
    Chand, P.
    Sarre, S.
    Colwell, A.
    NEUROLOGY, 2006, 67 (05) : 897 - 899
  • [10] Levodopa Therapy for Parkinson's Disease: Pharmacokinetics and Pharmacodynamics
    LeWitt, Peter A.
    MOVEMENT DISORDERS, 2015, 30 (01) : 64 - 72
12345